ГОСТ Р ИСО 10993.7-99
М. Teratogenic Stud)-of Ethylene Oxide and Propylene Oxide and n-Butyl Acetate (NIOSH Contract No. 210—80—
0013). Richland, WA: Battclle Pacific Northwest Laboratories, 1982. (Cited in EPA, 1985)
f34] Handlos, V Determination ofgas residuals in ethylene oxide sterilized materials —A literaturesurvey. Archiv
Pharm. Chemi. Sci. 4 1976; pp. 73—80
135] Handlos, V. The hazards of ethylene oxide sterilization. Arch. Pharm. Chemi. Sci. 7 1979; pp. 939—949
]36] Hartman, P.A. and Bowman, P.B. Simple GLC determination of ethylene oxide and its reaction products
in drug and formulations. J Pharm. Sci. 66(6) 1977, pp. 789—792
137) Health Industry Manufacturers’ Assiciation. Guidelines for the Analysis of Ethylene Oxide Residues in
Medical Devices (HIMA Document No. I, Vo]. 20 Washington, DC: HIMA, 1980
|38| Hollingworth, R., Rowe, V., Oycn, F., McCallistcr, D. and Spencer. H. Toxicityofethylene oxide determined
on experimental animals. AMA Arch. Ind. Health. 13 1956; pp. 217—227
[39] Hubaux, A and Gilbert, V. Decision and detection limits for linear calibration curves. Anal. Chem. 42(8)
1970; pp. 849-855
[40] Improved detection and separation ofglycols and ethylene oxide residues using GC. (Bulletin 789), Supelco,
Inc.; 1980
[411 Jacobson. K., Hackley. E. and Feinsilver, L. The toxicity of inhaled ethylene oxide and propylene oxide
vapors. AMA Arch. Ind. Health. 13 1956; pp. 237—244
[42] Japan Association of Disposable Medical Device Industries. Guideline for ethylene oxide sterilization of
disposable medical devices (second edition). Dec. 1989
|43] Johnson, M. Metabolism of chloroethanol in the rat Bioche. Pharmacol. 16 1967a; pp 185-199
[44] Jonson, M. Detoxication of ethylene chlorohydrin. Fd. Cosmet. Tox. 5 1967 b; p. 499
|4S| Joncs-Price, C., Kimmel, T., Markes, T., Ledoux. T., Reel, J., Fisher, P., Langhoff-Paschke, L. and Man,
M. Teratologic Evaluation of Ethylene Oxide (CAS No. 75—78—8) in New Zealand White Rabbits (Final report
RB80-EO, NJEHS Contract No. l-ES-2127). Research Triangle Park, NC: National Institute of Environmental Health
Sciences, 1982. (Cited in EPA, 1985)
[46] Joncs-Price, C., Marks, T , Ledoux, T., Reel, J., Fischer, P.. LanghofT-Paschke. L.. Marr, M. and Kimmel.
C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107—07—3) in New Zealand White Rabbits (PB85-
170959). Research Triangle Park, NC: National Institute of Environmental Health Sciences, 1985a
[47] Joncs-Price, C , Mrks, T., Ledoux, T., Reel, J., Fisher, P., Langhoff-Paschke. L., Marr, M. and Kimmel.
C. Teratologic Evaluation of ethylene Chlorohydrin (CAS No. 107—07—3) in CD-I mice (PB85-I72104). Research
Triangle Park, NC: National Institute of Environmental Health Sciences, 1985b
[48] Karel, L., Landing, B. and Harvey, T. The intrapcritoncal toxicity ofsome glycols, glycol ethers and phthalatcs
in mice. Fed. Proceedings. 6 1947; p. 342
[49] Kashtock, M. Use ofspecific retention volumes in evaluation of various types ofcolumns for use in the trace
determination of ethylene glycol by gas chronatography. J. Chromatogr. 176 1979; pp. 25—35
[50] Kaye, M.M. and Novell, T.G. Statistical evaluation of methods using headspace gas chromatography for the
determination of ethylene oxide. Analyst. 110 1985; pp. 1067—1071
[51] Kikuchi, H., Nakamura, Л. andTsuji, K. Gas chromatographic determination with electron capture detection
of residual ethylene oxide in intraocular lenses. J. Assoc. OIT. Anal. Chem. 71 1988; pp. 1057—1062
[52] Krocs, R.. Bock, B. and Martis, L Ethylene oxide extraction and stability in water and blood. Personal
communication to the AAM1 Committee, Jan. 1985
[53] Kulkami, R.K., Bartak, D., Ousterliout, D.K. and Leonard. F. Determination of Residual ethylene oxide in
catheters by gas-liquid chromatography J. Biomed. Mat Res. 2 1968; pp. 165—171
[54] Laborde. J. and Kimmel, C The teratogenicity of ethylene oxide administered intravenously to mice. Tox.
Appl Pharm. 56 1980; pp. 16—22
[55] Landen, W.O., Thompson, D.W. and Floyd, K.M Determination of ethylene oxide and ethylene glycol in
wet sutgical dressings. FDA By-Lines, No 2, 1971
[56] Latven, A and Molitor, H. Comparison of the toxic, hypnotic and irritating properties of eight organic
solvents. J. Pharm. Exp. Thcr. 65 1939; pp. 89—94
[57] Lawrence, W., Turner, J. and Autian, J. Toxicity of ethylene chlorohydrin I: Acute toxicity studies. J. Pharm.
Sci. 60(4) 1971a; pp. 568-571
[58] Lawrence. W., m Itoh, R., Turner, J. and Autian, J. Toxicity ofethylene chlorohydrin 11; Subchronic toxicity
and special tests. J. Pharm. Sci. 60(8) 1971b; pp. 1163—1168
[59] Lawrence, W., Dilligham, E.. Turner, J. and Autian. J. Toxicity profile of chloroaceialdchyde. J. Pharm. Sci.
61(1) 1972; pp. 19-25
[60] Lee. H.T., Daniel. A. and Walker, C. Conformance test procedures (CTP) for verifying the labelling claims
for precision, bias, and interferences in in-vitro diagnostic devices used for the quantitative measurement of analytes in
human body fluids. In: Bureau of Medical Devices Biometrics Report 8202. Silver Spring, MD: Food and Drug
Administration, Apr. 1982
|611 Long, G.L. and Winefordner, J.D. Limit of detection —A closer look at the ШРАС definition. Anal. Chem.
55(7) 1983; pp. 712A-724A
[62] Lynch, D., Lewis, T., Moorma, W.t SabharwaJ. P. and Burg, J. Toxic and mutagenic effects of ethylene
oxide and propylene oxid on spcrmatogenic functions in Cynomolgus monkeys. Toxicologist. 3:60
[63] Lynch, D., Lewis, T.. Moorman, W., Burg. J., Groth, D., Khan, A., Ackerman. L. and Cockerell, B.
36